These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36282706)

  • 41. Angelman Syndrome Protein Ube3a Regulates Synaptic Growth and Endocytosis by Inhibiting BMP Signaling in Drosophila.
    Li W; Yao A; Zhi H; Kaur K; Zhu YC; Jia M; Zhao H; Wang Q; Jin S; Zhao G; Xiong ZQ; Zhang YQ
    PLoS Genet; 2016 May; 12(5):e1006062. PubMed ID: 27232889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ube3a, the E3 ubiquitin ligase causing Angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle Rpn10.
    Lee SY; Ramirez J; Franco M; Lectez B; Gonzalez M; Barrio R; Mayor U
    Cell Mol Life Sci; 2014 Jul; 71(14):2747-58. PubMed ID: 24292889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imprinted expression of UBE3A in non-neuronal cells from a Prader-Willi syndrome patient with an atypical deletion.
    Martins-Taylor K; Hsiao JS; Chen PF; Glatt-Deeley H; De Smith AJ; Blakemore AI; Lalande M; Chamberlain SJ
    Hum Mol Genet; 2014 May; 23(9):2364-73. PubMed ID: 24363065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Light activates Ube3a, an Angelman syndrome-associated gene, by mediating the chromatin structures during postnatal development of mouse retina.
    Lin CW; Cheng YC; Yang CH; Huang HS
    J Neurochem; 2023 Dec; 167(6):766-777. PubMed ID: 37994169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice.
    Schmid RS; Deng X; Panikker P; Msackyi M; Breton C; Wilson JM
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33411694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential therapeutic approaches for Angelman syndrome.
    Bi X; Sun J; Ji AX; Baudry M
    Expert Opin Ther Targets; 2016; 20(5):601-13. PubMed ID: 26558806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angelman Syndrome Due to UBE3A Gene Mutation.
    Goswami JN; Sahu JK; Singhi P
    Indian J Pediatr; 2018 May; 85(5):390-391. PubMed ID: 29250725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. UBE3A regulates MC1R expression: a link to hypopigmentation in Angelman syndrome.
    Low D; Chen KS
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):944-52. PubMed ID: 21733131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recovery of Angelman syndrome rat deficits with UBE3A protein supplementation.
    Dodge A; Morrill NK; Weeber EJ; Nash KR
    Mol Cell Neurosci; 2022 May; 120():103724. PubMed ID: 35367589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain.
    Bailus BJ; Pyles B; McAlister MM; O'Geen H; Lockwood SH; Adams AN; Nguyen JT; Yu A; Berman RF; Segal DJ
    Mol Ther; 2016 Mar; 24(3):548-55. PubMed ID: 26727042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced Nociception in Angelman Syndrome Model Mice.
    McCoy ES; Taylor-Blake B; Aita M; Simon JM; Philpot BD; Zylka MJ
    J Neurosci; 2017 Oct; 37(42):10230-10239. PubMed ID: 28931574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ube3a reinstatement mitigates epileptogenesis in Angelman syndrome model mice.
    Gu B; Carstens KE; Judson MC; Dalton KA; Rougié M; Clark EP; Dudek SM; Philpot BD
    J Clin Invest; 2019 Jan; 129(1):163-168. PubMed ID: 30352049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurodevelopmental profile of siblings with Angelman syndrome due to pathogenic UBE3A variants.
    Sadhwani A; Willen JM; Miller H; Barbieri-Welge R; Horowitz LT; Noll LM; Peters S; Hundley R; Bird LM; Tan WH
    J Intellect Disabil Res; 2020 Mar; 64(3):246-250. PubMed ID: 31854050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes.
    Sonzogni M; Hakonen J; Bernabé Kleijn M; Silva-Santos S; Judson MC; Philpot BD; van Woerden GM; Elgersma Y
    Mol Autism; 2019; 10():23. PubMed ID: 31143434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.
    Mulherkar SA; Jana NR
    Neurobiol Dis; 2010 Dec; 40(3):586-92. PubMed ID: 20696245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypersociability in the Angelman syndrome mouse model.
    Stoppel DC; Anderson MP
    Exp Neurol; 2017 Jul; 293():137-143. PubMed ID: 28411125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic variation of UBE3A is associated with schizotypy in a population of typical individuals.
    Salminen I; Read S; Hurd P; Crespi B
    Psychiatry Res; 2019 May; 275():94-99. PubMed ID: 30897394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.
    Jiang YH; Pan Y; Zhu L; Landa L; Yoo J; Spencer C; Lorenzo I; Brilliant M; Noebels J; Beaudet AL
    PLoS One; 2010 Aug; 5(8):e12278. PubMed ID: 20808828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of a deletion of exons 8-16 of the UBE3A gene in familial Angelman syndrome using a semi-quantitative dosage PCR based assay.
    Boyes L; Wallace AJ; Krajewska-Walasek M; Chrzanowska KH; Clayton-Smith J; Ramsden S
    Eur J Med Genet; 2006; 49(6):472-80. PubMed ID: 16740422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subcellular organization of UBE3A in human cerebral cortex.
    Burette AC; Judson MC; Li AN; Chang EF; Seeley WW; Philpot BD; Weinberg RJ
    Mol Autism; 2018; 9():54. PubMed ID: 30364390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.